Alginate Formulations: Current Developments in the Race for Hydrogel-Based Cardiac Regeneration

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Research

Background:

• Cardiovascular diseases, particularly myocardial infarction (MI), are a leading global cause of death.
• Cardiac regeneration offers a promising strategy for repairing irreversible damage post-MI by preserving tissue structure and cell function.
• Alginate has been identified as a key biomaterial for cell preservation and delivery in cardiovascular applications.

Purpose of the Study:

• To review the properties and applications of alginate in cardiac regeneration.
• To highlight alginate's role in overcoming limitations in recellularization and revascularization of infarcted cardiac tissue.
• To discuss ongoing developments and clinical trials involving alginate for myocardial infarction recovery.

Main Methods:

• Review of scientific literature on alginate hydrogels for cardiac regeneration.
• Analysis of alginate's characteristics, including cell preservation and delivery capabilities.
• Examination of pre-clinical and clinical trial data related to alginate in cardiovascular diseases.

Main Results:

• Alginate hydrogels demonstrate significant potential for preserving cellular behavior and tissue cytoarchitecture.
• Functionalization of alginate with specific molecules and factors is crucial for enhancing regenerative capacity.
• Current clinical trials show promising, yet limited, success in recellularization and revascularization of infarcted areas.

Conclusions:

• Alginate is a valuable biomaterial for cardiac regeneration, with ongoing research focused on optimizing its functionalization.
• Addressing limitations in tissue integration and vascularization is key to maximizing alginate's therapeutic benefits.
• Further clinical investigations are essential to fully establish alginate-based therapies for myocardial infarction.